2018 Korean society of hypertension guidelines for the management of hypertension: part III-hypertension in special situations

Clinical Hypertension
Kwang-Il KimShung Chull Chae

Abstract

Treatment of hypertension improves cardiovascular, renal, and cerebrovascular outcomes. However, the benefit of treatment may be different according to the patients' characteristics. Additionally, the target blood pressure or initial drug choice should be customized according to the special conditions of the hypertensive patients. In this part III, we reviewed previous data and presented recommendations for some special populations such as diabetes mellitus, chronic kidney disease, elderly people, and cardio-cerebrovascular disease.

References

Dec 14, 1995·The New England Journal of Medicine·UNKNOWN National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group
Oct 23, 1998·Journal of Human Hypertension·J A StaessenR Fagard
Jan 20, 2000·The New England Journal of Medicine·UNKNOWN Heart Outcomes Prevention Evaluation Study InvestigatorsG Dagenais
May 12, 2000·Journal of the American College of Cardiology·J S GottdienerR C Boineau
May 3, 2001·The New England Journal of Medicine·J TuomilehtoUNKNOWN Finnish Diabetes Prevention Study Group
Sep 22, 2001·The New England Journal of Medicine·E J LewisUNKNOWN Collaborative Study Group
Sep 22, 2001·The New England Journal of Medicine·B M BrennerUNKNOWN RENAAL Study Investigators
Feb 8, 2002·The New England Journal of Medicine·William C KnowlerUNKNOWN Diabetes Prevention Program Research Group
Apr 3, 2002·Annals of Internal Medicine·Seamus P WheltonJiang He
Oct 11, 2002·Archives of Internal Medicine·Françoise ForetteUNKNOWN Systolic Hypertension in Europe Investigators
Nov 21, 2002·JAMA : the Journal of the American Medical Association·Jackson T WrightUNKNOWN African American Study of Kidney Disease and Hypertension Study Group
Dec 7, 2002·Hypertension·James R Sowers, Steven Haffner
Dec 20, 2002·JAMA : the Journal of the American Medical Association·UNKNOWN ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatm
Feb 14, 2003·The New England Journal of Medicine·Lindon M H WingUNKNOWN Second Australian National Blood Pressure Study Group
Apr 2, 2003·Annals of Internal Medicine·Tomas BerlUNKNOWN Irbesartan Diabetic Nephropathy Trial. Collaborative Study Group
May 22, 2003·JAMA : the Journal of the American Medical Association·Bruce M PsatyNoel S Weiss
Jun 13, 2003·The New England Journal of Medicine·Denis L ClementUNKNOWN Office versus Ambulatory Pressure Study Investigators
Jun 21, 2003·Stroke; a Journal of Cerebral Circulation·Joachim SchraderUNKNOWN Acute Candesartan Cilexetil Therapy in Stroke Survivors Study Group
Oct 25, 2003·Stroke; a Journal of Cerebral Circulation·Parveen RashidPhilip Bath
Nov 15, 2003·Lancet·Fiona Turnbull, UNKNOWN Blood Pressure Lowering Treatment Trialists' Collaboration
Dec 6, 2003·Hypertension·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Dec 19, 2003·The New England Journal of Medicine·John D McConnellUNKNOWN Medical Therapy of Prostatic Symptoms (MTOPS) Research Group

❮ Previous
Next ❯

Citations

Oct 28, 2019·Korean Circulation Journal·Sungha Park
Apr 14, 2020·Korean Circulation Journal·Jinho Shin, Myeong Chan Cho
May 8, 2020·Clinical Hypertension·Jing Liu
Jan 27, 2021·Clinical Hypertension·Hae Young LeeUNKNOWN Korean Society of Hypertension
Dec 18, 2020·Frontiers in Cardiovascular Medicine·Xianghong Meng, Xiaoyong Xu
Jun 5, 2021·Korean Circulation Journal·Hae Young LeeMyeong Chan Cho
Jun 11, 2021·Current Hypertension Reports·Johann HerberthJan N Basile

❮ Previous
Next ❯

Methods Mentioned

BETA
amputation
biopsy
hormone replacement therapy

Software Mentioned

SPRINT

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Zhonghua nei ke za zhi
Committee of Cardio-Cerebro-Vascular Diseases of Gerontological Society of China, Chinese College of Cardiovascular Physicians of Chinese Medical Doctor Association
Journal of Managed Care Pharmacy : JMCP
Frederic R Curtiss
© 2021 Meta ULC. All rights reserved